MMP9 and neoplasm: Notably, treatment with either cromolyn or levetiracetam blunted MMP9 production by MCs in vivo (Figures 5C,D and Supplementary Figure 2), but it did not affect MMP9 expression in T23 tumor cells (Figure 5E).